Panagora Asset Management’s Protara Therapeutics TARA Stock Holding History

Panagora Asset Management’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-43,796	Closed	-$233K	–	1272
2025 Q4	$233K	Buy	+43,796	New	+$243K	﹤0.01%	1078
2021 Q3	–	Sell	-55	Closed	-$1K	–	2332
2021 Q2	$1K	Sell	55 -5,866	-99%	-$66.4K	﹤0.01%	2716
2021 Q1	$93K	Buy	+5,921	New	+$110K	﹤0.01%	2041
2019 Q1	–	Sell	-334	Closed	-$30K	–	2573
2018 Q4	$30K	Buy	334 +62	+23%	+$4.38K	﹤0.01%	2119
2018 Q3	$21K	Sell	272 -114	-30%	-$10.5K	﹤0.01%	2214
2018 Q2	$38K	Hold	386	–	–	﹤0.01%	2090
2018 Q1	$39K	Hold	386	–	–	﹤0.01%	2096
2017 Q4	$29K	Buy	+386	New	+$31K	﹤0.01%	2132

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Panagora Asset Management's TARA Position: Q1 2026 in Review

Panagora Asset Management sold out of Protara Therapeutics (TARA) in Q1 2026, closing a stake of 43,796 shares — an estimated $233K sold.

Panagora Asset Management first reported a position in TARA in Q4 2017 and held it in 8 quarters. The position peaked at $233K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Panagora Asset Management reported no remaining Protara Therapeutics position as of Q1 2026 after selling out during the quarter.
Panagora Asset Management sold 43,796 Protara Therapeutics shares in Q1 2026, an estimated $233K.
Panagora Asset Management first reported a position in Protara Therapeutics in Q4 2017 and held it in 8 quarters.
Panagora Asset Management's Protara Therapeutics position peaked at $233K in Q4 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.